Streetbeat News

Analyst Ratings

SLG

Over the past 3 months, 8 analysts have published their opinions on SL Green Realty (NYSE:SLG) stock, with an average 12-month price target of $24.0, representing a 31.82% decrease from the previous average price target of $35.20.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 7:02 pm

RENT

JMP Securities analyst Andrew Boone reiterated a Market Outperform rating on Rent the Runway Inc (NASDAQ:RENT) with a price target of $6. The company is focused on improving customer onboarding and inventory depth, and plans to introduce AI-powered search. RTR expects active subscriber growth to accelerate to +25% Y/Y by year end.

Portfolio Pulse from Shivani Kumaresan

June 14, 2023 | 7:01 pm

SIGI

Selective Insurance Gr (NASDAQ:SIGI) has received 5 indifferent analyst ratings in the last quarter, with an average price target of $102.0, implying an upside from the current price of $97.49. The average price target has increased by 1.8% from the previous average of $100.20.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 7:01 pm

MODN

Over the past 3 months, 8 analysts have published their opinion on Model N (NYSE:MODN) stock, with an average 12-month price target of $41.38, down 5.95% from the previous average of $44.00. The ratings include 3 bullish, 4 somewhat bullish, and 1 indifferent.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 7:01 pm

AXTA

Analysts have provided various ratings for Axalta Coating Sys (NYSE:AXTA) within the last quarter, with an average price target of $32.88, implying an upside from the current price of $32.42. The current average has increased by 13.38% from the previous average price target of $29.00.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 7:01 pm

GHI

In the last 3 months, 4 analysts have provided 12-month price targets for Greystone Housing Impact (NYSE:GHI), with an average price target of $19.75, a 2.85% decrease from the previous average of $20.33.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 7:00 pm

ACAD

Acadia Pharmaceuticals announced the addition of ACP-101, a Phase 3 development candidate for hyperphagia in Prader-Willi syndrome, to its rare disease portfolio. The company acquired worldwide rights to ACP-101 by acquiring Levo Therapeutics in June 2022. Analysts believe ACP-101 has a strong strategic fit and adds upside optionality for Acadia's future revenue growth.

Portfolio Pulse from Vandana Singh

June 14, 2023 | 6:59 pm

CRM

Oppenheimer analyst Brian Schwartz reiterated an Outperform rating on Salesforce (NYSE:CRM) with a price target of $235. He believes the company is well positioned to benefit from vendor consolidation trends, AI product prioritization, and improving business efficiency. Salesforce is also poised to gain from margin growth, increased multi-cloud adoption, and success with verticalized solutions.

Portfolio Pulse from Nabaparna Bhattacharya

June 14, 2023 | 6:58 pm

DIN

Wedbush analyst Nick Setyan downgraded Dine Brands Global Inc (NYSE:DIN) to Neutral from Outperform and reduced the price target to $65 from $80. Setyan is bearish on Applebee's and IHOP's below-consensus same-store sales (SSS) growth and lowered their growth estimates for Q2 and future years. The analyst also sees no sign of meaningful growth in share repurchases and believes management is prioritizing rebuilding cash.

Portfolio Pulse from Lekha Gupta

June 14, 2023 | 6:56 pm

VRNT

Needham analyst Ryan MacDonald reiterated a Buy rating on Verint Systems Inc. (NASDAQ:VRNT) with a price target of $50, citing the company's AI-driven CX Automation initiatives. The analyst believes these bots will drive incremental efficiency and curb rising labor costs, and expects Verint's customer engagement business to support a near 30% EBITDA margin.

Portfolio Pulse from Nabaparna Bhattacharya

June 14, 2023 | 6:03 pm